Scientific Background and Reference Sources
Alexander, E. K., Kennedy, G. C., Baloch, Z. W., Cibas, E. S., Chudova, D., Diggans, J., . . . Haugen, B. R. (2012). Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. N Engl J Med, 367(8), 705-715. doi:10.1056/NEJMoa1203208
Chudova, D., Wilde, J. I., Wang, E. T., Wang, H., Rabbee, N., Egidio, C. M., . . . Kennedy, G. C. (2010). Molecular classification of thyroid nodules using high-dimensionality genomic data. J Clin Endocrinol Metab, 95(12), 5296-5304. doi:10.1210/jc.2010-1087
Cibas, E.S., Ali, S.Z. (2009). Conference NCITFSotS. The Bethesda System For Reporting Thyroid Cytopathology. Am J Clin Pathol, 132:658-665
Gharib, H., Papini, E., Garber, J. R., Duick, D. S., Harrell, R. M., Hegedüs, L., . . . Vitti, P. (2016). AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ASSOCIAZIONE MEDICI ENDOCRINOLOGI MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR THE DIAGNOSIS AND MANAGEMENT OF THYROID NODULES – 2016 UPDATE. http://dx.doi.org/10.4158/EP161208.GL. doi:i1530-891X-22-s1-1
Haugen, B. R., Alexander, E. K., Bible, K. C., Doherty, G. M., Mandel, S. J., Nikiforov, Y. E., . . . Wartofsky, L. (2016). 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid, 26(1), 1-133. doi:10.1089/thy.2015.0020
Hodak, S. P., & Rosenthal, D. S. (2013). Information for clinicians: commercially available molecular diagnosis testing in the evaluation of thyroid nodule fine-needle aspiration specimens. Thyroid, 23(2), 131-134. doi:10.1089/thy.2012.0320
Labourier, E., Shifrin, A., Busseniers, A. E., Lupo, M. A., Manganelli, M. L., Andruss, B., . . . Beaudenon-Huibregtse, S. (2015). Molecular Testing for miRNA, mRNA, and DNA on Fine-Needle Aspiration Improves the Preoperative Diagnosis of Thyroid Nodules With Indeterminate Cytology. J Clin Endocrinol Metab, 100(7), 2743-2750. doi:10.1210/jc.2015-1158
Mazzaferri, EL. (1993) Thyroid carcinoma: Papillary and folicullar. In:Mazzaferri EL, Samaan N, eds. Endocrine Tumors. Cambridge: Blackwell Scientific Publications: 278-333.
McIver, B., Castro, M. R., Morris, J. C., Bernet, V., Smallridge, R., Henry, M., . . . Reddi, H. (2014). An independent study of a gene expression classifier (Afirma) in the evaluation of cytologically indeterminate thyroid nodules. J Clin Endocrinol Metab, 99(11), 4069-4077. doi:10.1210/jc.2013-3584
NCCN, N. C. C. N. (2016). NCCN Clinical Practice Guidelines in Oncology: Thyroid Carcinoma Version 1.2016. Retrieved from https://www.nccn.org/professionals/physician_gls/f_guidelines.asp#detection
NCCN, N. C. C. N. (2017). NCCN Clinical Practice Guidelines in Oncology: Thyroid Carcinoma Version 2.2017. Retrieved from https://www.nccn.org/professionals/physician_gls/f_guidelines.asp#detection
Nikiforov, Y. E., Carty, S. E., Chiosea, S. I., Coyne, C., Duvvuri, U., Ferris, R. L., . . . Nikiforova, M. N. (2014). Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay. Cancer, 120(23), 3627-3634. doi:10.1002/cncr.29038
Nikiforov, Y. E., Ohori, N. P., Hodak, S. P., Carty, S. E., LeBeau, S. O., Ferris, R. L., . . . Nikiforova, M. N. (2011). Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples. J Clin Endocrinol Metab, 96(11), 3390-3397. doi:10.1210/jc.2011-1469
Nikiforov, Y. E., Yip, L., & Nikiforova, M. N. (2013). New strategies in diagnosing cancer in thyroid nodules: impact of molecular markers. Clin Cancer Res, 19(9), 2283-2288. doi:10.1158/1078-0432.ccr-12-1253
Ross, D. (2017). Diagnostic approach to and treatment of thyroid nodules - UpToDate. In D. Cooper (Ed.), UpToDate. Waltham. MA.
Xing, M., Haugen, B. R., & Schlumberger, M. (2013). Progress in molecular-based management of differentiated thyroid cancer. Lancet, 381(9871), 1058-1069. doi:10.1016/s0140-6736(13)60109-